Hikma Pharmaceuticals Sustainability Profile

Hikma Pharmaceuticals is committed to advancing health and wellbeing by providing access to medicine as central to its sustainability agenda. The company operates with a duty to act responsibly for its people, patients, communities, and the planet, having identified four focus areas to drive positive impact. Hikma maintains an ESG rating of 3.2 out of 5 and conducts regular sustainability assessments, including a double materiality assessment in 2024 to refresh its broader sustainability strategy.